VISIT NUTRACEUTICALS WORLD AT BOOTH #3560

EKF Introduces Mobile Data Management Solution for the DiaSpect Analyzer at Medica

By EKF Diagnostics | 11.13.17

New POC smartphone application enhances DiaSpect Tm's use for rapid, remote hemoglobin analysis.

EKF Diagnostics, a global in-vitro diagnostics company, marked its participation in the world's largest medical trade fair by unveiling the POC Connect—a data management smartphone application for its DiaSpect Tm hemoglobin analyzer.

At Medica 2017, EKF demonstrated DiaSpect Tm, the only reagent-free hemoglobin analyzer with mobile connectivity. Lightweight and palm-sized, the DiaSpect Tm analyzer delivers laboratory quality hemoglobin results within two seconds at the point-of-care (POC). Now with the availability of POC Connect, this makes it ideal for mobile health checks and anemia screening in a range of locations, environments and climatic conditions.
 
The new POC Connect mobile app is the world’s first mobile data management solution for a reagent-free hemoglobin testing device, according to EKF Diagnostics. It is a simple android application that enables the storage, access and transmission of hemoglobin results directly from the DiaSpect Tm analyzer to a smartphone via Bluetooth technology. DiaSpect Tm can be purchased with integrated Bluetooth, meaning there is no need to purchase an additional external Bluetooth dongle.
 
This new POC solution will prove useful in countries with challenging environmental and geographical conditions where remote hemoglobin testing and access to internet can be difficult. All that is needed is an android phone and DiaSpect Tm device to record hemoglobin results with dates and times and then add unique identifiers, such as Patient ID, User ID, QC information, Cuvette LOT numbers, and comments. Data is synched and stored on the smartphone in a history list for easy access. Data can then be transferred at any time as a protected CSV file and added to a central database or lab information system (LIS) as required.
 
Highlighting the significance of the new POC Connect App, Katja Lemburg, EKF Diagnostics, said, “Connectivity is a key requirement for POC devices. Within developing countries there is a growing demand for mobile data management solutions due to the lack of permanently available internet infrastructure and the bi-passing of more traditional land-line installations. Having connected POC hemoglobin testing with the DiaSpect Tm via Bluetooth and 3G/4G mobile networks makes it an ideal solution to record data in the absence of internet connection or electricity. In addition, mobile heath care services are expanding in industrialized countries, therefore, our smartphone-based connectivity solution could also play a part in these remote clinics.”
 
Hand held and portable, DiaSpect Tm is ideal for point-of-care testing (POCT) not only due to its measurement speed, but also through its battery life of 40 days continuous use, and up to 10,000 tests, without need for a recharge. Additionally, its reagent-free microcuvettes have up to 2.5 years shelf life, even after opening, and are unaffected by temperature or humidity. These disposable cuvettes can be stored from 0 to 50 degrees Celsius, meaning temperature controlled storage is not necessary—short term storage is even possible at -30 degrees Celsius to 70 degrees Celsius for 24 hours. This makes the device highly suited for testing in remote and/or hot and humid environmental conditions, or sites with low test volumes.
 
DiaSpect Tm is easy to use, requiring minimal training, as the user simply collects a capillary or venous blood sample of <10 µL in the microcuvette before inserting straight into the analyzer. Also making it ideal for POCT use in all locations, DiaSpect Tm is factory calibrated against the HiCN reference method in accordance with ICSH. No re-calibration or maintenance is needed, and it undertakes an automatic self-check between every measurement.
 
EKF Diagnostics Holdings plc, which includes the EKF Diagnostics, Stanbio Laboratory and DiaSpect brands, specializes in the development, production and worldwide distribution of point-of-care analyzers for use in the detection and management of diabetes and anemia, and also in sports and maternal medicine. EKF products are sold in more than 100 countries around the globe, through a network of specialist distributors. Point-of-care diagnostics: EKF Diagnostics designs and manufactures world-class diagnostic devices, as well as distributing rapid test kits for infectious diseases and pregnancy. The EKF analyzer range is used widely in GP surgeries, pharmacies, blood banks, sports clinics, hospitals and laboratories for glucose, lactate, hemoglobin, hematocrit and HbA1c measurement.
 
Central laboratory: EKF, through its wholly owned subsidiary, Stanbio Laboratory (Boerne, Texas, USA), manufactures a comprehensive range of clinical chemistry reagents, as well as associated analyzers. In addition, EKF Life Sciences (Elkhart, Indiana, USA) manufactures enzymes used in reagent development and also provides contract fermentation facilities.

EKF Diagnostics is showcasing the data management application for DiaSpect Tm in Hall 3, Stand C70.